The oral drug delivery industry focuses on methods to administer medications via the mouth, ensuring effective absorption. Companies operate in areas like drug formulation, innovative delivery systems, and a range of pharmaceutical products. The sector is increasingly driven by the demand for improved patient compliance and novel technologies that facilitate easier intake of complex therapeutics. Insights suggest a trend towards less invasive administration routes, with a growing interest in utilizing advanced dosage forms like orally dissolving tablets and sublingual delivery systems to enhance the efficacy and experience of treatment.

In this list, twelve companies span various sizes and locales—from startups to established firms. Founded between 1907 and 2023, these companies specialize in oral drug delivery products thanks to their innovations in formulation and manufacturing. They are strategically located in regions including the United States, Europe, and Asia, facilitating global outreach. This variety showcases a commitment to developing patient-friendly solutions that meet evolving healthcare needs. Each company offers unique advancements, from thin films to complex generics, positioning this industry as a dynamic participant in healthcare advancements.

Continue reading to discover the top oral drug delivery companies.

Top 25 Oral Drug Delivery Companies

1. Nemera

• Website: nemera.net
• Ownership type: Private Equity
• Headquarters: Fontaines-Sur-Saône, Auvergne-Rhône-Alpes, France
• Employee distribution: France 61%, United States (USA) 19%, Brazil 10%, Other 11%
• Latest funding: October 2018
• Founded year: 2015
• Headcount: 1001-5000
• LinkedIn: nemera

Nemera, founded in 2015 and based in Fontaines-Sur-Saône, France, is a private equity-backed medical device manufacturer. The company specializes in drug delivery device solutions and combination product services, partnering with pharmaceutical, biotechnology, and generic industries. Their offerings include device development, clinical manufacturing, and innovation support, aimed at maximizing treatment efficacy and ensuring safe medication delivery. With a workforce of approximately 1,390 employees, Nemera operates globally, with a significant presence in France, the United States, Brazil, Germany, and Poland. Their commitment to patient-centric solutions is evident in their focus on oral administration devices, among other delivery methods, making them a relevant player in the drug delivery market.

2. Pharmathen

• Website: pharmathen.com
• Ownership type: Private Equity
• Headquarters: Marousi, North Athens Regional Unit, Greece
• Employee distribution: Greece 96%, Other 4%
• Latest funding: $1.9B, July 2021
• Founded year: 1969
• Headcount: 1001-5000
• LinkedIn: pharmathen

Pharmathen, founded in 1969 and based in Marousi, Greece, is a pharmaceutical company that specializes in innovative drug delivery technologies. With a workforce of over 1,000 employees, Pharmathen has established itself as a significant player in the pharmaceutical industry. The company focuses on developing advanced pharmaceutical products, including long-acting injectables, sustained release formulations, and preservative-free ophthalmic products. Pharmathen operates globally, serving pharmaceutical companies and healthcare providers in more than 90 countries. Their commitment to research and development is evident, with an annual investment of €35 million and a pipeline of over 40 products. Pharmathen's manufacturing facilities are approved by both the US FDA and EU authorities, ensuring high-quality production standards. The company has a strong emphasis on enhancing patient compliance and improving healthcare outcomes through its innovative technologies and product offerings.

3. Bluepharma

• Website: bluepharmagroup.com
• Ownership type: Private
• Headquarters: Coimbra, Coimbra, Portugal
• Employee distribution: Portugal 99%
• Founded year: 2001
• Headcount: 501-1000
• LinkedIn: bluepharma

Bluepharma is a privately owned pharmaceutical company based in Coimbra, Portugal, founded in 2001. The company has grown significantly over the years, now comprising 20 companies that cover all stages of the pharmaceutical industry value chain. Bluepharma focuses on the research, development, manufacturing, and commercialization of medicines and health products, with a strong emphasis on innovative drug delivery systems. They are particularly noted for their manufacturing capabilities, producing up to 3 billion units of oral solid dosage forms annually. Their facilities are equipped with cutting-edge technology and adhere to stringent quality standards, including Good Manufacturing Practices (GMP). Bluepharma exports 89% of its production to over 40 countries, showcasing its international reach and commitment to quality and sustainability in the pharmaceutical sector.

4. Vivera Pharmaceuticals

• Website: viverapharmaceuticals.com
• Ownership type: Private
• Headquarters: Newport Beach, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $440.0M, November 2020
• Founded year: 2018
• Headcount: 51-200
• LinkedIn: viverapharmaceuticals

Vivera Pharmaceuticals, Inc. is a biopharma and medtech company based in Newport Beach, California, founded in 2018. The company specializes in innovative therapies and medical devices, with a strong focus on drug delivery systems. Vivera holds global exclusivity for the patented TABMELT sublingual drug delivery system, which allows for effective pharmaceutical use. They also have developed the ZICOH electronic dispensing device, showcasing their commitment to advancing medical technology. With a workforce of around 51-200 employees, Vivera is actively engaged in research and development aimed at addressing pain management challenges and improving health outcomes. The company has secured significant funding, amounting to $440 million as of November 2020, which supports its ongoing projects and innovations in the healthcare sector.

5. Fertin Pharma A/S

• Website: fertin.com
• Ownership type: Corporate
• Headquarters: Vejle, Denmark
• Employee distribution: Denmark 89%, India 7%, Canada 4%
• Latest funding: $82.0M, July 2021
• Founded year: 1915
• Headcount: 501-1000
• LinkedIn: fertin-pharma-as

Fertin Pharma A/S, based in Vejle, Denmark, is a pharmaceutical manufacturer with a rich history dating back to 1915. The company focuses on developing and producing innovative oral and intra-oral delivery systems for active ingredients, catering to both pharmaceutical and nutraceutical sectors. Fertin's product range includes unique offerings like the Zapliq® fast liquefiable tablet, compressed and extruded gums, lozenges, and pouch powders. These products are designed to improve consumer adherence by providing effective and pleasant dosage forms. With approximately 733 employees and operations in multiple countries, Fertin combines over 30 years of experience in oral drug delivery with advanced research and development capabilities. The company has also received significant funding, amounting to $82 million in July 2021, which supports its ongoing innovation and expansion efforts.

6. Biograil

• Website: biograil.com
• Ownership type: Venture Capital
• Headquarters: Roskilde, Denmark
• Employee distribution: Denmark 100%
• Latest funding: Seed, October 2022
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: biograil

Biograil, founded in 2019 and based in Roskilde, Denmark, is a pharmaceutical company dedicated to advancing drug delivery systems. The company specializes in its proprietary BIONDD™ technology, which enables the conversion of injectable medications into oral capsules. This innovation not only enhances patient compliance but also improves treatment efficacy by overcoming the barriers typically associated with oral dosing of biologics. Biograil primarily serves pharmaceutical companies and healthcare providers seeking effective solutions for biologic drug delivery. The company has garnered attention in the industry, participating in significant conferences and forming collaborations with major pharmaceutical players, indicating its active role in the drug delivery sector. As of October 2022, Biograil secured seed funding to support its research and development efforts, further demonstrating its commitment to advancing oral drug delivery solutions.

7. Tapemark

• Website: tapemark.com
• Ownership type: Corporate
• Headquarters: West Saint Paul, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: August 2022
• Founded year: 1952
• Headcount: 51-200
• LinkedIn: tapemark

Tapemark, founded in 1952 and based in West Saint Paul, Minnesota, is a pharmaceutical company that specializes in drug delivery systems. With a workforce of around 53 employees, Tapemark focuses on providing innovative solutions for drug administration, particularly through transdermal patches and oral films. They serve a variety of pharmaceutical clients, offering a full range of services including formulation, analytical services, and manufacturing. Their proprietary platforms, such as IontoPatch™ and MacroPerm™, highlight their commitment to advancing drug delivery technologies. Tapemark has established itself as a key player in the development of oral thin films, which are gaining traction for their ease of use and effectiveness, especially among populations that struggle with traditional oral medications. Their expertise in this area positions them as a valuable partner for pharmaceutical companies seeking to enhance their drug delivery options.

8. Lyndra Therapeutics

• Website: lyndra.com
• Ownership type: Venture Capital
• Headquarters: Watertown, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series E-K, $101.0M, December 2023
• Founded year: 2015
• Headcount: 51-200
• LinkedIn: lyndra

Lyndra Therapeutics, founded in 2015 and based in Watertown, Massachusetts, is a pharmaceutical company dedicated to revolutionizing drug delivery systems. The firm specializes in long-acting oral therapies, which are designed to improve medication adherence for patients suffering from chronic health conditions. Their flagship LYNX® drug delivery platform has been developed to allow patients to take a week’s worth of medication in a single dose, significantly reducing the burden of daily pill regimens. Lyndra's research focuses on various therapeutic areas, including treatments for schizophrenia, diabetes, and opioid use disorder. The company has received substantial funding, with a recent Series E round raising $101 million in December 2023, underscoring investor confidence in their innovative approach and potential market impact.

9. LTS Lohmann Therapie-Systeme AG

• Website: ltslohmann.com
• Ownership type: Private
• Headquarters: Andernach, Rhineland-Palatinate, Germany
• Employee distribution: Germany 59%, United States (USA) 28%, Israel 11%, Other 2%
• Founded year: 1984
• Headcount: 1001-5000
• LinkedIn: lts---lohmann-therapie-systems-ag

LTS Lohmann Therapie-Systeme AG, founded in 1984 and based in Andernach, Germany, is a private pharmaceutical company that specializes in innovative drug delivery systems. The company focuses on developing transdermal therapeutic systems, oral thin films, and microneedle technologies, which are designed to enhance patient compliance and improve therapeutic outcomes. With a global presence, LTS partners with pharmaceutical companies to provide comprehensive solutions from research and development to manufacturing. Their commitment to innovation is evident in their extensive portfolio of technologies aimed at non-invasive drug delivery, which includes oral thin films that offer rapid delivery and improved patient adherence. LTS operates with a strong emphasis on quality, with manufacturing facilities that meet stringent regulatory standards, ensuring the reliability of their products in the healthcare market.

10. NAL Pharma/IA Capital

• Website: nalpharma.com
• Ownership type: Private
• Headquarters: Hong Kong S.A.R
• Founded year: 2006
• Headcount: 51-200
• LinkedIn: nal-pharma-ia-capital

NAL Pharma, founded in 2006 and based in Hong Kong, is a private biopharmaceutical company dedicated to advancing drug delivery systems and novel dosage forms. The company focuses on developing proprietary Drug Delivery System (DDS) technologies that enhance the effectiveness of medications across various therapeutic areas, including oncology, pain management, and central nervous system disorders. NAL Pharma's innovative approaches include the Bio-FX Fast-Onset Orally-Dissolving Film (ODF) technology, which allows for rapid absorption and improved patient compliance. They also work with major pharmaceutical companies to convert patent-expiring drugs into new formulations with enhanced features. NAL Pharma operates internationally, collaborating with partners to expedite product development and commercialization in global markets.

11. ARx, LLC

• Website: arxpharma.com
• Ownership type: Private
• Headquarters: Glen Rock, Pennsylvania, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2005
• Headcount: 51-200
• LinkedIn: arx_llc

ARx, LLC, founded in 2005 and based in Glen Rock, Pennsylvania, is a pharmaceutical manufacturer that specializes in drug delivery systems. The company focuses on developing and producing oral thin films and transdermal patches, which are designed to improve patient compliance and therapeutic outcomes. ARx partners with both generic and branded drug companies to create FDA-approved products, showcasing their commitment to quality and regulatory compliance. With a team that leverages over 60 years of expertise in polymer science and production technologies, ARx has established itself as a key player in the oral drug delivery market. Their capabilities include drug product development, quality and analytical support, and commercial manufacturing, allowing them to support clients from product ideation to market launch. The company has a history of innovation, having been involved in the launch of the first over-the-counter thin films for systemic drug delivery and expanding into prescription applications. This experience, combined with their focus on patient-centric solutions, underscores their relevance in the pharmaceutical industry.

12. Eskayef Pharmaceuticals Ltd.

• Website: skfbd.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 100%
• Founded year: 1990
• Headcount: 5001-10000
• LinkedIn: eskayef-pharmaceuticals-limited

Eskayef Pharmaceuticals Ltd., established in 1990, is a private pharmaceutical company based in Dhaka, Bangladesh. It specializes in the manufacture and marketing of therapeutic drugs and health products. The company has built a reputation for providing high-quality medications, including oral solid dosages, and has expanded its operations to export to over 70 countries. Eskayef has made notable advancements in the production of generic drugs, particularly during the COVID-19 pandemic, where they developed treatments like Remdesivir and Molnupiravir. Their facilities are equipped with modern technology, and they adhere to stringent quality standards, as evidenced by their accreditations from various international regulatory authorities. Eskayef is committed to serving healthcare providers and patients with affordable and innovative medicines, reflecting their mission to enhance global health.

13. Adare Pharma Solutions

• Website: adarepharmasolutions.com
• Ownership type: Private Equity
• Headquarters: Philadelphia, Pennsylvania, United States (USA)
• Employee distribution: United States (USA) 59%, Italy 36%, Other 6%
• Latest funding: September 2020
• Founded year: 2015
• Headcount: 501-1000
• LinkedIn: adare-pharmaceuticals

Adare Pharma Solutions, founded in 2015 and based in Philadelphia, Pennsylvania, operates as a Contract Development and Manufacturing Organization (CDMO) with a focus on the pharmaceutical industry. The company provides a comprehensive suite of services that includes product development, formulation development, and commercial-scale manufacturing, specifically targeting oral dosage forms. Adare's specialized technology platforms address critical challenges in drug delivery, such as taste masking, controlled release, and solubility enhancement. They cater primarily to pharmaceutical companies looking to enhance their product offerings. With a workforce of over 500 employees and facilities in the United States and Italy, Adare Pharma Solutions has established itself as a significant player in the industry, having developed and manufactured numerous products that are marketed globally.

14. Abon Pharmaceuticals, LLC

• Website: abonpharma.com
• Ownership type: Private
• Headquarters: Chestnut Ridge, New York, United States (USA)
• Employee distribution: United States (USA) 89%, United Kingdom (UK) 5%, Portugal 5%
• Founded year: 2009
• Headcount: 11-50
• LinkedIn: abon-pharmaceuticals-llc

Abon Pharmaceuticals, LLC, founded in 2009 and based in Chestnut Ridge, New York, is a private pharmaceutical company that focuses on the development of complex generics and proprietary products. The company is dedicated to drug delivery research and manufacturing, offering a variety of injectable and oral dosage forms. Abon serves healthcare providers and pharmaceutical companies, aiming to provide innovative drug solutions that enhance patient compliance and product quality. Their recent achievements include receiving FDA approval for a generic version of Carafate® (sucralfate) Oral Suspension, which highlights their active role in the oral drug delivery space. Abon employs a science-based approach to product development, leveraging modern technology and a highly qualified team of scientists to ensure robust processing and efficient dosage form design. Their pipeline includes several oral dosage forms, indicating a strong commitment to advancing oral drug delivery solutions.

15. Graviti Pharmaceuticals

• Website: gravitipharma.com
• Ownership type: Private
• Headquarters: Hyderabad, Telangana, India
• Employee distribution: India 100%
• Founded year: 2012
• Headcount: 501-1000
• LinkedIn: graviti-pharmaceuticals

Graviti Pharmaceuticals, based in Hyderabad, India, is a private pharmaceutical manufacturer established in 2012. The company focuses on producing high-quality generic drugs, particularly in the area of complex formulations and novel drug delivery systems. With a workforce of around 410 employees, Graviti is dedicated to enhancing healthcare accessibility through its innovative and cost-effective products. The company is part of the Yashoda Group, which has a long-standing reputation in healthcare services. Graviti invests significantly in research and development, allocating nearly 8% of its revenue to this area, which is above the industry average. This investment supports their goal of developing specialized molecules that provide high value to customers. Graviti's product portfolio includes a wide range of therapeutic categories and dosage forms, with a strong focus on oral drug delivery systems. Their commitment to quality is evident in their adherence to Good Manufacturing Practices and a culture of continuous improvement. Graviti Pharmaceuticals aims to lower healthcare costs while ensuring that patients receive effective treatment options.

16. HERMES PHARMA - Get the dose right

• Website: hermes-pharma.com
• Ownership type: Family Owned
• Headquarters: Pullach, Bavaria, Germany
• Employee distribution: Germany 78%, Austria 20%, United Arab Emirates 2%
• Founded year: 1907
• Headcount: 501-1000
• LinkedIn: hermes-pharma---a-division-of-hermes-arzneimittel-gmbh

HERMES PHARMA, based in Pullach, Bavaria, Germany, is a family-owned pharmaceutical company that has been active since 1907. The company specializes in the development and manufacture of user-friendly oral dosage forms, catering to the needs of patients who face difficulties swallowing conventional tablets and capsules. HERMES PHARMA's product portfolio includes a variety of innovative dosage forms such as orally disintegrating granules, chewable tablets, effervescent tablets, instant drinks, and lozenges. They also provide a full suite of services, including project management, research and development, formulation development, analytical services, clinical studies, and regulatory support. This comprehensive approach allows them to assist pharmaceutical companies and healthcare providers in bringing effective and user-friendly products to market. HERMES PHARMA has a strong commitment to quality, employing QbD/PAT-driven processes and maintaining specialist manufacturing facilities. Their expertise in user-friendly formulations is further highlighted by their focus on magnesium supplements and other dietary products, which are designed to meet modern consumer expectations for convenience and taste.

17. Avery Pharmaceuticals Pvt. Ltd.

• Website: averypharma.co.in
• Ownership type: Private
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 100%
• Founded year: 2017
• Headcount: 51-200
• LinkedIn: avery-pharmaceuticals

Avery Pharmaceuticals Pvt. Ltd., founded in 2017 and based in Ahmedabad, Gujarat, India, is a private pharmaceutical company dedicated to transforming drug delivery methods. The company is a wholly-owned subsidiary of Arrow Greentech Limited and focuses on developing innovative solutions that enhance patient care. Their flagship product, the Mouth Dissolving Strip (MDS), utilizes patented technology to provide a fast and effective alternative to traditional oral medications. This product is particularly beneficial for patients who face challenges with conventional dosing methods, such as children, the elderly, and those with swallowing difficulties. Avery's commitment to quality is evident in their state-of-the-art manufacturing facility, which adheres to international standards. The company actively engages in research and development to expand its product pipeline and improve existing formulations, ensuring they meet the evolving needs of healthcare providers and patients alike.

18. Softgel Healthcare Private Limited

• Website: softgelhealthcare.com
• Ownership type: Private Equity
• Headquarters: Chennai, Tamil Nadu, India
• Employee distribution: India 98%, Other 2%
• Latest funding: September 2022
• Founded year: 2006
• Headcount: 501-1000
• LinkedIn: softgel-healthcare-pvt-ltd

Softgel Healthcare Private Limited, founded in 2006 and based in Chennai, Tamil Nadu, India, operates as a contract development and manufacturing organization (CDMO) in the pharmaceutical industry. The company specializes in the production of softgel products, catering to the needs of pharmaceutical companies and healthcare providers. Their offerings include a wide array of formulations, such as cold and flu remedies, omega-3 capsules, and various pain relief medications. Softgel Healthcare emphasizes innovation and quality, with a robust research and development team dedicated to creating effective health solutions. They maintain high standards in manufacturing and quality control, ensuring that their products meet both national and international regulatory requirements. With a workforce of around 363 employees, the company serves clients across multiple continents, including North America, Europe, and Asia, showcasing their global reach and operational capabilities.

19. Pharmatek

• Website: pharmatek.com
• Ownership type: Corporate
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: September 2016
• Founded year: 1999
• Headcount: 201-500
• LinkedIn: pharmatek-laboratories-inc-

Pharmatek, known as Catalent, is a contract development and manufacturing organization based in San Diego, California. Founded in 1999, the company has grown to employ between 201 and 500 individuals. Catalent specializes in providing pharmaceutical and biotechnology services, focusing on drug development, manufacturing, and delivery. Their offerings include a wide range of oral dosage forms, such as tablets, capsules, and softgels, as well as innovative solutions like orally disintegrating tablets and bioavailability enhancement technologies. Catalent's OptiForm® Solution Suite is designed to streamline the drug development process, helping clients navigate the complexities of bringing new therapies to market. The company has not reported any recent funding, indicating a stable operational status since its last funding round in 2016.

20. APOLO PHARMA Laboratoire

• Website: apolopharma-lab.com
• Ownership type: Private
• Headquarters: Bamako, Bamako, Mali
• Employee distribution: India 67%, Mali 33%
• Founded year: 2019
• Headcount: 1-10
• LinkedIn: apolo-pharma-laboratoires

APOLO PHARMA Laboratoire, founded in 2019 and located in Bamako, Mali, is a private pharmaceutical manufacturer dedicated to producing high-quality pharmaceutical products. The company focuses on developing essential medications that enhance health outcomes for healthcare professionals and institutions. With a workforce of around 72 employees, a significant portion of their team is based in India, reflecting a blend of local and international expertise. Their product range includes oral medications such as tablets and syrups, as well as injectable solutions, all manufactured under stringent European quality standards. APOLO PHARMA aims to establish itself as a reference in the pharmaceutical industry, aspiring to obtain WHO certification for its products to serve both the domestic and growing African markets. Their commitment to research and development, particularly in addressing local health needs, further underscores their active role in the pharmaceutical sector.

21. Toralgen

• Website: toralgen.com
• Ownership type: Venture Capital
• Headquarters: Indianapolis, Indiana, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Seed, $8.3M, December 2020
• Founded year: 2017
• Headcount: 1-10
• LinkedIn: toralgen

Toralgen, founded in 2017 and based in Indianapolis, Indiana, is a biotechnology company dedicated to advancing drug delivery systems. The company specializes in a unique poly-bile nanoparticle platform designed to improve the oral delivery of biologics, particularly for treating diabetes and autoimmune disorders. With a small team of around 23 employees, Toralgen has made significant strides in the biopharmaceutical sector, having raised $8.3 million in seed funding to support its innovative research. The company collaborates with pharmaceutical partners to develop novel formulations that replace traditional injection methods with more patient-friendly oral options. Toralgen's technology has been recognized in the industry, being named one of the top five emerging drug delivery startups, and it has been accepted into the FDA's Emerging Technology Program, highlighting its commitment to innovation in drug delivery.

22. Profarma Sh.a

• Website: profarma.al
• Ownership type: Private
• Headquarters: Tirana, Tirana, Albania
• Employee distribution: Albania 70%, Brazil 27%, Congo 3%
• Founded year: 1945
• Headcount: 201-500
• LinkedIn: profarma-sh-a

Profarma Sh.a, based in Tirana, Albania, is a private pharmaceutical company founded in 1945. With a workforce of approximately 172 employees, Profarma is dedicated to producing a wide array of healthcare products, including oral solid dosage forms, injectable solutions, and galenic formulations. The company serves healthcare providers, pharmacies, and patients, ensuring access to essential medications for various health conditions. Profarma operates primarily in the pharmaceutical manufacturing sector, emphasizing quality and innovation in its product offerings. Their production facilities are equipped to handle a significant volume of oral solid dosage forms, producing 134 different types of tablets and capsules. This focus on oral drug delivery is complemented by their commitment to generics development and regulatory compliance, positioning them as a relevant player in the pharmaceutical industry.

23. Laboratorio Kemex S.A.

• Website: kemexlab.com
• Ownership type: Private
• Headquarters: General Pacheco, Buenos Aires, Argentina
• Employee distribution: Argentina 98%, Other 2%
• Founded year: 1969
• Headcount: 51-200
• LinkedIn: laboratorio-kemex-s.a.

Laboratorio Kemex S.A., founded in 2007 and based in General Pacheco, Buenos Aires, Argentina, is a private pharmaceutical company dedicated to the production of oncological medicines. The company manufactures both injectable and oral solid dosage forms, ensuring a focus on quality and safety in its operations. With a workforce of approximately 200 employees, Kemex is committed to continuous improvement and expansion in both national and international markets. They have established partnerships in over 15 countries, reflecting their ambition to enhance access to essential medications for cancer treatment. Kemex adheres to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), which underscores their commitment to maintaining high standards in pharmaceutical production. Their product portfolio includes around 80 different items, primarily targeting the oncology sector, and they actively engage in research and development to innovate and improve their offerings.

24. Salix Pharmaceuticals

• Website: salix.com
• Ownership type: Corporate
• Headquarters: Bridgewater, New Jersey, United States (USA)
• Employee distribution: United States (USA) 99%
• Latest funding: February 2015
• Founded year: 1988
• Headcount: 501-1000
• LinkedIn: salix-pharmaceuticals

Salix Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Bridgewater, New Jersey, founded in 1988. The company is dedicated to developing and marketing innovative treatments specifically for gastrointestinal disorders. With a workforce of approximately 761 employees, Salix serves healthcare professionals and patients by providing effective solutions for chronic GI conditions. Their product portfolio includes notable oral medications like XIFAXAN, used for treating hepatic encephalopathy and irritable bowel syndrome, and TRULANCE, aimed at chronic idiopathic constipation. Salix emphasizes research and development, striving to enhance patient outcomes and quality of life for those affected by gastrointestinal issues. The company operates under the umbrella of Bausch Health Companies Inc., which further supports its mission to innovate in the pharmaceutical space.

25. Azurity Pharmaceuticals

• Website: azurity.com
• Ownership type: Private Equity
• Headquarters: Woburn, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 58%, India 40%, Other 2%
• Latest funding: March 2018
• Founded year: 1998
• Headcount: 501-1000
• LinkedIn: azuritypharmaceuticals

Azurity Pharmaceuticals, based in Woburn, Massachusetts, is a private equity-owned pharmaceutical company founded in 1998. The company is dedicated to creating innovative dose-form solutions that cater to various medical conditions, particularly for patients with unmet needs. Azurity's product offerings include a range of high-quality medications, with a significant emphasis on oral solutions and injectable formulations. Their portfolio features several FDA-approved products across therapeutic areas such as cardiovascular, central nervous system, endocrinology, gastrointestinal, immunology, and oncology. Notably, Azurity has developed unique oral formulations, including the first FDA-approved oral solutions for certain medications, which highlights their expertise in oral drug delivery. The company actively seeks to improve patient access to effective treatments, ensuring that healthcare providers and patients can benefit from their innovations.

Oral Drug Delivery Insights: Key Companies

Want to Find More Oral Drug Delivery Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!